Markedly reduced expression of platelet c-mpl receptor in essential thrombocythemia

Blood

Volumn 90, Issue 10, 1997, Pages 4031-4038

  Horikawa, Yoko ^b   Matsumura, Itaru ^b   Hashimoto, Koji ^b   Shiraga, Masamichi ^b   Kosugi, Satoru ^b   Tadokoro, Seiji ^b   Kato, Takashi ^b   Miyazaki, Hiroshi ^b   Tomiyama, Yoshiaki ^b   Kurata, Yoshiyuki ^b   Matsuzawa, Yuji ^b   Kanakura, Yuzuru ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RECEPTOR; FIBRINOGEN RECEPTOR; MESSENGER RNA; THROMBOPOIETIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MALE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; THROMBOCYTHEMIA;

EID: 0030732423     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.10.4031     Document Type: Article

References (53)

1. Wehmeier A, Scharf RE, Fricke S, Schneider W: Bleeding and thrombosis in chronic myeloproliferative disorders: Relations of platelet disorders to clinical aspects of the disease. Haemostasis 19:251, 1989
2. Schafer AL: Bleeding and thrombosis in the myeloproliferative disorders. Blood 64:1, 1984
3. Fenaux P, Simon M, Caulier MT, Lai JL, Goudemand J, Bauters F: Clinical course of essential thrombocythemia in 147 cases. Cancer 66:549, 1990
4. Chistolini A, Mazzucconi MG, Ferrari A, La Verde G, Ferrzza G, Gragoni F, Vitale F, Arcieri R, Mandelli F: Essential thrombocythemia: A retrospective study on the clinical course of 100 patients. Haematologica 75:537, 1990
5. Fialkow PJ, Faguet GB, Jacobson RJ, Vaidya K, Murphy S: Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell. Blood 58:916, 1981
6. Mazur EM, Cohen JL, Bogart L: Growth characteristics of circulating hematopoietic progenitor cells from patients with essential thrombocythemia. Blood 71:1544, 1988
7. Zauli G, Catani L, Gugliotta L, Gaggioli L, Vitale L, Mattioli M, Aglietta M, Bagnara GP: Essential thrombocythemia: Impaired regulation of megakaryocyte progenitors. Int J Cell Cloning 9:43, 1991
8. Battegay EJ, Thomssen C, Nissen C, Gudat F, Speck B: Endogenous megakaryocyte colonies from peripheral blood in precursor cell cultures of patients with myeloproliferative disorders. Eur J Haematol 42:321, 1989
9. Hehlmann R, Jahn M, Baumann B, Kopcke W: Essential thrombocythemia. Cancer 61:2487, 1988
10. Bellucci S, Janvier M, Tobelem G, Flandrin G, Charpak Y, Berger R, Boiron M: Essential thrombocythemias. Cancer 58:2440, 1986
11. Cortellazzo S, Barbui T, Bassan R, Dini E: Abnormal aggregation and increased size of platelets in myeloproliferative disorders. Thromb Haemost 43:127, 1980
12. Preston FE, Martin JF, Stewart RW, Davies-Jones GAB: Thrombocytosis, circulating platelets aggregates and neurological dysfunction. Br Med J 2:1561, 1979
13. Bazzan M, Tamponi G, Schinco P, Marranca D, Pileri A, Bertello F, Pennone M, Bassignana A, Casaccia M: Platelet behavior in essential thrombocythemia: A study of 31 cases. Eur J Haematol 43:350, 1989
14. Wehmeier A, Fricke S, Scharf RE, Schneider W: A prospective study of haemostatic parameters in relation to the clinical course of myeloproliferative disorders. Eur J Haematol 45:191, 1990
15. Kaushansky K: Thrombopoietin: The primary regulator of platelet production. Blood 86:419, 1995
16. Methia N, Louache F, Vainchenker W, Wendling F: Oligodeoxynucleotides antisense to the c-mpl specifically inhibit in vitro megakaryocytopoiesis. Blood 82:1395, 1993
17. Kaushansky K, Lok S, Holly RD, Broudy VC, Lin N, Bailey MC, Forstrom JW, Buddle MM, Oort PJ, Hagen FS, Roth GJ, Papayannopoulou T, Foster DC: Promotion of megakaryocyte progenitor expansion and differentiation by the c-mpl ligand thrombopoietin. Nature 369:568, 1994
18. Farese AM, Hunt P, Boone T, MacVittie TJ: Recombinant human megakaryocyte growth and development factor stimulates thrombopoiesis in normal nonhuman primates. Blood 85:54, 1995
19. Gurney AL, Carver-Moore K, Sauvage FJ, Moore MW: Thrombocytopenia in c-mpl-deficient mice. Science 265:1445, 1994
20. Alexander WS, Robert AW, Nicola NA, Li R, Metcalf D: Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietin receptor c-Mpl. Blood 87:2162, 1996
21. de Sauvage FJ, Carver-Moore K, Luoh SM, Ryan A, Dowd M, Eaton DL, Moore MW: Physiological regulation of early and late stages of megakaryopoiesis by thrombopoietin. J Exp Med 183:651, 1996
22. Miyakawa Y, Oda A, Drucker BJ, Kato T, Miyazaki H, Handa M, Ikeda Y: Recombinant thrombopoietin induces rapid protein tyrosine phosphorylation of Janus kinase 2 and Shc in human blood platelets. Blood 86:23, 1995
23. Miyakawa Y, Oda A, Druker BJ, Miyazaki H, Handa M, Ohashi H, Ikeda Y: Thrombopoietin induces tyrosine phosphorylation of STAT3 and STAT5 in human blood platelets. Blood 87:439, 1996
24. Ezumi Y, Takayama H, Okuma M: Thrombopoietin, c-Mpl ligand, induces tyrosine phosphorylation of Tyk2, Jak2, and STAT3, and enhances agonist-induced aggregation in platelets in vitro. FEBS Letts 374:48, 1995
25. Kojima H, Hamazaki Y, Nagata Y, Todokoro K, Nagasawa T: Modulation of platelet activation in vitro by thrombopoietin. Thromb Haemost 74:1541, 1995
26. Chen J, Herceg-Harjacek L, Groopman JE, Grabarek J: Regulation of platelet activation in vitro by the c-Mpl ligand thrombopoietin. Blood 86:4054, 1995
27. Matsumura I, Kanakura Y, Kato T, Ikeda H, Horikawa Y, Ishikawa J, Kitayama H, Nishiura T, Tomiyama Y, Miyazaki H, Matsuzawa Y: The biologic properties of recombinant human thrombopoietin in the proliferation and megakaryocytic differentiation of acute myeloblastic leukemia cells. Blood 88:3074, 1996
28. Pidard D, Montgomery RR, Bennet JS, Kunicki TJ: Interaction of AP2, a monoclonal antibody specific for the human platelet glycoprotein IIb/IIIa complex, with intact platelets. J Biol Chem 258:12582, 1983
29. Murphy S, Hand H, Rosenthal D, Laszlo J: Essential thrombo-cytopenia: An interim report from the polycythemia vera study group. Semin Hematol 23:177, 1986
30. Tomiyama Y, Kashiwagi H, Kosugi S, Shiraga M, Kanayama Y, Kurata Y, Matsuzawa Y: Abnormal processing of the glycoprotein IIb transcript due to a nonsense mutation in exon 17 associated with Glanzmann's thrombasthenia. Thromb Haemost 73:756, 1995
31. Kosugi S, Kurata Y, Tomiyama Y, Tahara T, Kato T, Tadokoro S, Shiraga M, Honda S, Kanakura Y, Matsuzawa Y: Circulating thrombopoietin level in chronic immune thrombocytopenic purpura. Brit J Haematol 93:704, 1996
32. Tahara T, Usuki K, Sato H, Ohashi H, Morita H, Tsumura H, Matsumoto A, Miyazaki H, Urabe A, Kato T: A sensitive sandwich ELISA for measuring thrombopoietin in human serum: Serum thrombopoietin levels in healthy volunteers and in patients with haematopoietic disorders. Brit J Haematol 93:783, 1996
33. WAF1/Cip1 by STAT5. Mol Cell Biol 17:2933, 1997
34. Matsumura I, Kanakura Y, Kato T, Ikeda H, Ishikawa J, Horikawa Y, Hashimoto K, Moriyama Y, Tsujimura T, Nishiura T, Miyazaki H, Matsuzawa Y: Growth response of acute myeloblastic leukemia cells to recombinant human thrombopoietin. Blood 86:703, 1995
35. Vigon I, Mornon JP, Cocault L, Mitjavila MT, Tambourin P, Gisselbrecht S, Souyri M: Molecular cloning and characterization of MPL, the human homologue of v-mpl oncogene: Identification of a member of the hematopoietic growth factor receptor superfamily. Proc Natl Acad Sci USA 89:5640, 1992
36. Kuter DJ, Rosenverg RD: Appearance of a megakaryocyte growth-promoting activity, megapoietin, during acute thrombocytopenia in the rabbit. Blood 84:1464, 1994
37. Emmons RVB, Reid DM, Cohen RL, Meng G, Young GM, Dunber CE, Shulman NR: Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. Blood 87:4068, 1996
38. Stoffel R, Wiestner A, Skoda RC: Thrombopoietin in the thrombocytopenic mice: Evidence against regulation at the mRNA level and for a direct regulatory role of platelets. Blood 87:567, 1996
39. Fielder PJ, Gurney AL, Stefanich E, Marian M, Moore MW, Carver-Moore K, de Sauvage FJ: Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets. Blood 87:2154, 1996
40. McCarty JM, Sprugel KH, Fox NE, Sabath DE, Kaushansky K: Murine thrombopoietin mRNA levels are modulated by platelet count. Blood 86:3668, 1995
41. Lowenberg B, Touw P: Hematopoietic growth factors and their receptors in acute leukemia. Blood 81:281, 1993
42. Furitsu T, Tsujimura T, Tono T, Ikeda H, Kitayama H, Koshimizu U, Sugahara H, Butterfield JH, Ashman LK, Kanayama Y, Matsuzawa Y, Kitamura Y, Kanakura Y: Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest 92:1736, 1993
43. Ridge SA, Worwood M, Oscier D, Jacobs A, Padua RA: FMS mutations in myelodysplastic, leukemic, and normal subjects. Proc Natl Acad Sci USA 87:1377, 1990
44. Drachman JG, Griffin JD, Kaushansky K: The C-Mpl ligand (thrombopoietin) stimulates tyrosine phosphorylation of JAK2, Shc, and c-Mpl. J Biol Chem 270:4979, 1995
45. Tortolani PJ, Johonston JA, Bacon CM, McVicar DW, Shimosaka A, Linnekin D, Longo DL, O'Shea JJ: Thrombopoietin induces tyrosine phosphorylation and activation of Janus kinase, Jak2. Blood 85:3444, 1995
46. Gurney AL, Wong SC, Henzel WJ, Sauvage FJ: Distinct regions of c-mpl cytoplasmic domain are coupled to the JAK-STAT signal transduction pathway and Shc phosphorylation. Proc Natl Acad Sci USA 92:5292, 1995
47. Pallard C, Gouileux F, Benit L, Cocault L, Souyri M, Levy D, Groner B, Gisselbrecht S, Dusanter-Fourt I: Thrombopoietin activates a STAT5-like factor in hematopoietic cells. EMBO J 14:2847, 1995
48. Deveaux S, Filipe A, Lemarchandel V, Ghysdael J, Romeo P-H, Mignotte V: Analysis of the thrombopoietin receptor (MPL) promoter implicates GATA and Ets proteins in the coregulation of megakaryocyte-specific genes. Blood 87:4678, 1996
49. Lemarchandel V, Ghysdael J, Mignotte V, Rahuel C, Romeo P-H: GATA and Ets cis-acting sequences mediate megakaryocyte specific expression. Mol Cell Biol 13:668, 1993
50. Kaywin P, Mcdonough M, Insel P, Shattil SJ: Platelet function in essential thrombocythemia: Decreased epinephrine responsiveness associated with a deficiency of platelet α-adrenergic receptors. New Engl J Med 299:505, 1978
51. Schafer AI: Deficiencies of platelet lipoxygenase activity in myeloproliferative disorders. New Engl J Med 306:381, 1982
52. Cooper B, Schafer AI, Puchalsky D, Handin RI: Platelet resistance to prostaglandin D2 in patients with myeloproliferative disorders. Blood 52:618, 1978
53. Moore A, Nachman RL: Platelet Fc receptor: Increased expression in myeloproliferative disease. J Clin Invest 67:1064, 1981